American journal of ophthalmology · 2025
Subretinal Fluid Duration and Clinical Outcomes in Central Serous Chorioretinopathy: An Analysis of Time-to-Photodynamic Therapy.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Funatsu Ryoh, Mihara Naohisa, Miyake Shoki, Okamura Koki, Imatsuji Hiroki, Sakono Takato, Shiihara Hideki, Sonoda Shozo, Sakamoto Taiji, Terasaki Hiroto
Аннотация
OBJECTIVE: To estimate the effect of prolonged serous retinal detachment (SRD) during the waiting period for photodynamic therapy (PDT) on clinical outcomes in patients with central serous chorioretinopathy (CSC).
DESIGN: Retrospective case series.
SUBJECTS: Consecutive patients with CSC who underwent PDT between January 2016 and August 2024. Patients whose SRD resolved spontaneously while awaiting PDT were excluded.
METHODS: We measured the best-corrected visual acuity (BCVA) and retinal layer thickness at baseline and on the day of PDT. We evaluated (1) the changes in these parameters during the waiting period and (2) the association between the duration of this period and the outcomes.
MAIN OUTCOME MEASURES: Associations of the time-to-PDT with 12-month BCVA, SRD remission at 12 months, and changes in retinal layer thickness during the waiting period.
RESULTS: Ninety-four patients (94 eyes) with CSC were included, with a mean age of 57.6 ± 12.2 years, a mean BCVA of 0.18 ± 0.24 logMAR (Snellen: 20/30), and a mean waiting period of 50.8 ± 50.2 days. The outer nuclear layer thinned significantly during the waiting period (mean reduction = 1.9 ± 4.4 μm, P = 3.4 × 10-5), and longer waiting times were associated with greater thinning (crude: β = -0.04, P = 3.5 × 10-6; adjusted: β = -0.04, P = 1.3 × 10-6). However, waiting duration was not significantly associated with 12-month treatment outcomes.
CONCLUSIONS: Our findings suggest that caution is warranted against prolonged subretinal fluid exposure beyond 1 to 2 months, as it may induce outer nuclear layer thinning.
DESIGN: Retrospective case series.
SUBJECTS: Consecutive patients with CSC who underwent PDT between January 2016 and August 2024. Patients whose SRD resolved spontaneously while awaiting PDT were excluded.
METHODS: We measured the best-corrected visual acuity (BCVA) and retinal layer thickness at baseline and on the day of PDT. We evaluated (1) the changes in these parameters during the waiting period and (2) the association between the duration of this period and the outcomes.
MAIN OUTCOME MEASURES: Associations of the time-to-PDT with 12-month BCVA, SRD remission at 12 months, and changes in retinal layer thickness during the waiting period.
RESULTS: Ninety-four patients (94 eyes) with CSC were included, with a mean age of 57.6 ± 12.2 years, a mean BCVA of 0.18 ± 0.24 logMAR (Snellen: 20/30), and a mean waiting period of 50.8 ± 50.2 days. The outer nuclear layer thinned significantly during the waiting period (mean reduction = 1.9 ± 4.4 μm, P = 3.4 × 10-5), and longer waiting times were associated with greater thinning (crude: β = -0.04, P = 3.5 × 10-6; adjusted: β = -0.04, P = 1.3 × 10-6). However, waiting duration was not significantly associated with 12-month treatment outcomes.
CONCLUSIONS: Our findings suggest that caution is warranted against prolonged subretinal fluid exposure beyond 1 to 2 months, as it may induce outer nuclear layer thinning.
Предметные рубрики MeSH
HumansCentral Serous ChorioretinopathyPhotochemotherapyRetrospective StudiesSubretinal FluidFemaleMaleVisual AcuityMiddle AgedTomography, Optical CoherencePhotosensitizing AgentsFluorescein AngiographyVerteporfinTime-to-TreatmentAgedTreatment OutcomeAdultFollow-Up StudiesFundus OculiRetinal Detachment